Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine for Painful Neuropathy
NCT01667029Phase 2Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- May 2013
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminosalicylic acid + sulphasalazine in peripheral neuropathy, sponsored by Massachusetts General Hospital. Started May 2013; status: terminated.
02
Drugs
5-aminosalicylic acid + sulphasalazine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT01667029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667029.